Literature DB >> 16091195

Linking KSHV to human cancer.

Emily L Wong1, Blossom Damania.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), has been linked to several malignancies in humans. KSHV is the etiologic agent associated with the development of Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's disease (MCD). KSHV is a double-stranded DNA virus that has been classified as a gammaherpesvirus. Here, we review the association of KSHV with human cancer, viral genes that may potentially be involved in the neoplastic process, and current therapies used to treat KS, PEL, and MCD.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16091195     DOI： 10.1007/s11912-005-0061-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  79 in total

1.  p53 inhibition by the LANA protein of KSHV protects against cell death.

Authors:  J Friborg; W Kong; M O Hottiger; G J Nabel
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

2.  Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

Authors:  Brian S Bowser; Scott M DeWire; Blossom Damania
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?

Authors:  F Samaniego; S Pati; J E Karp; O Prakash; D Bose
Journal:  J Natl Cancer Inst Monogr       Date:  2001

4.  Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.

Authors:  Ariela Noy; David T Scadden; Jeannette Lee; Bruce J Dezube; David Aboulafia; Anil Tulpule; Sharon Walmsley; Parkash Gill
Journal:  J Clin Oncol       Date:  2004-12-14       Impact factor: 44.544

5.  Occurrence of Kaposi's sarcoma in renal transplant recipients treated with low doses of cyclosporine.

Authors:  G Civati; G Busnach; B Brando; M L Broggi; C Brunati; G P Casadei; L Minetti
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

6.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.

Authors:  M A Cotter; C Subramanian; E S Robertson
Journal:  Virology       Date:  2001-12-20       Impact factor: 3.616

8.  The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway.

Authors:  Christine C Tomlinson; Blossom Damania
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Authors:  D W Northfelt; B J Dezube; J A Thommes; B J Miller; M A Fischl; A Friedman-Kien; L D Kaplan; C Du Mond; R D Mamelok; D H Henry
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544

10.  Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor.

Authors:  E Geras-Raaka; A Varma; I Clark-Lewis; M C Gershengorn
Journal:  Biochem Biophys Res Commun       Date:  1998-12-30       Impact factor: 3.575
View more
  16 in total

1.  Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen.

Authors:  Mel Campbell; Pei-Ching Chang; Steve Huerta; Chie Izumiya; Ryan Davis; Clifford G Tepper; Kevin Y Kim; Bogdan Shevchenko; Don-Hong Wang; Jae U Jung; Paul A Luciw; Hsing-Jien Kung; Yoshihiro Izumiya
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

2.  Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.

Authors:  Caitlin G Smith; Himanshu Kharkwal; Duncan W Wilson
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

3.  Lytic Replication and Reactivation from B Cells Is Not Required for Establishing or Maintaining Gammaherpesvirus Latency In Vivo.

Authors:  Arundhati Gupta; Shana M Owens; Darby G Oldenburg; Douglas W White; J Craig Forrest
Journal:  J Virol       Date:  2022-06-01       Impact factor: 6.549

4.  KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.

Authors:  Ashish Kumar; Yuanzhi Lyu; Yuichi Yanagihashi; Chanikarn Chantarasrivong; Vladimir Majerciak; Michelle Salemi; Kang-Hsin Wang; Tomoki Inagaki; Frank Chuang; Ryan R Davis; Clifford G Tepper; Kazushi Nakano; Chie Izumiya; Michiko Shimoda; Ken-Ichi Nakajima; Alexander Merleev; Zhi-Ming Zheng; Mel Campbell; Yoshihiro Izumiya
Journal:  Cell Rep       Date:  2022-05-10       Impact factor: 9.995

5.  Infection and persistence of rhesus monkey rhadinovirus in immortalized B-cell lines.

Authors:  John P Bilello; Sabine M Lang; Fred Wang; Jon C Aster; Ronald C Desrosiers
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus.

Authors:  Tamara K Nun; David J Kroll; Nicholas H Oberlies; Djaja D Soejarto; Ryan J Case; Pius Piskaut; Teatulohi Matainaho; Chelsey Hilscher; Ling Wang; Dirk P Dittmer; Shou-Jian Gao; Blossom Damania
Journal:  Mol Cancer Ther       Date:  2007-08       Impact factor: 6.261

7.  MiR99a modulates MMP7 and MMP13 to regulate invasiveness of Kaposi's sarcoma.

Authors:  Jun Zhang; Shan Wang; Linya Lu; GuangHui Wei
Journal:  Tumour Biol       Date:  2014-09-19

8.  Proximity Biotin Labeling Reveals Kaposi's Sarcoma-Associated Herpesvirus Interferon Regulatory Factor Networks.

Authors:  Ashish Kumar; Michelle Salemi; Resham Bhullar; Sara Guevara-Plunkett; Yuanzhi Lyu; Kang-Hsin Wang; Chie Izumiya; Mel Campbell; Ken-Ichi Nakajima; Yoshihiro Izumiya
Journal:  J Virol       Date:  2021-04-12       Impact factor: 5.103

9.  Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.

Authors:  Yoshihiro Izumiya; Keisuke Kobayashi; Kevin Y Kim; Mamata Pochampalli; Chie Izumiya; Bogdan Shevchenko; Don-Hong Wang; Steve B Huerta; Anthony Martinez; Mel Campbell; Hsing-Jien Kung
Journal:  PLoS Pathog       Date:  2013-08-22       Impact factor: 6.823

10.  Virus-associated lymphomagenesis.

Authors:  V Z Tarantul
Journal:  Int J Biomed Sci       Date:  2006-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.